Lukoon
Key Drivers Fueling Growth in the Viral Inactivation Market
Biopharmaceutical safety is non-negotiable, and viral inactivation technologies are central to achieving it. Demand for these solutions is rising as biologics production expands and regulations tighten. Understanding the forces behind this growth helps technology providers, manufacturers, and investors plan effectively. A primary driver of the viral inactivation market is stringent regulatory...
31 Views